Association of SGLT2 Inhibitors with Reduced Hepatocellular Carcinoma Risk in Patients with Type 2 Diabetes. Choi J, Nguyen VH, Przybyszewski E, Song J, et al. Am J Gastroenterol 2025 Dec 16. doi: 10.14309/ajg.0000000000003889.

Read + Share

Amedeo Smart

Independent Medical Education

Choi J, Nguyen VH, Przybyszewski E, Song J, et al. Association of SGLT2 Inhibitors with Reduced Hepatocellular Carcinoma Risk in Patients with Type 2 Diabetes. Am J Gastroenterol 2025 Dec 16. doi: 10.14309/ajg.0000000000003889.
PMID: 41400268